Blumenfeld, Carl and Schulz, Michael D. and Hetts, Steven and Grubbs, Robert H. (2017) Functionalizing iron oxide with genomic DNA: Materials for drug capture. In: 253rd American Chemical Society National Meeting & Exposition, 2-6 April 2017, San Francisco, CA. https://resolver.caltech.edu/CaltechAUTHORS:20170503-152605584
Full text is not posted in this repository. Consult Related URLs below.
Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20170503-152605584
Abstract
Chemotherapy agents are well known for producing severe side-effects. One approach to mitigating this offtarget damage is to deliver the chemotherapy directly to the tumor via transarterial chemoembolization, or similar procedures, and then sequestering any chemotherapeutic that enters systemic circulation. Materials capable of such drug capture have yet to be fully realized. We report the synthesis of genomic DNAfunctionalized iron oxide nanoparticles, which we used to capture three common chemotherapy agents (doxorubicin, cisplatin, and epirubicin). Drug capture was studied in biol. relevant solns. including phosphate buffered saline, human serum, and porcine whole blood. The efficacy of these nanomaterials indicates that drug capture is a viable strategy for mitigating the harmful side-effects assocd. with chemotherapy.
Item Type: | Conference or Workshop Item (Paper) | ||||||
---|---|---|---|---|---|---|---|
Related URLs: |
| ||||||
ORCID: |
| ||||||
Additional Information: | © 2017 American Chemical Society. | ||||||
Record Number: | CaltechAUTHORS:20170503-152605584 | ||||||
Persistent URL: | https://resolver.caltech.edu/CaltechAUTHORS:20170503-152605584 | ||||||
Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | ||||||
ID Code: | 77174 | ||||||
Collection: | CaltechAUTHORS | ||||||
Deposited By: | Tony Diaz | ||||||
Deposited On: | 04 May 2017 01:28 | ||||||
Last Modified: | 19 Nov 2020 00:44 |
Repository Staff Only: item control page